• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的分子通路在坏疽性脓皮病患者中被破坏,并与疾病的严重程度相关。

Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease.

机构信息

Department of Advanced Diagnostics, Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", 34137, Trieste, Italy.

Department of Pathology, Federal University of Pernambuco, Recife, 50670-901, Brazil.

出版信息

Sci Rep. 2023 Mar 25;13(1):4919. doi: 10.1038/s41598-023-31914-z.

DOI:10.1038/s41598-023-31914-z
PMID:36966241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10039684/
Abstract

Pyoderma gangrenosum (PG) is a rare inflammatory skin disease classified within the spectrum of neutrophilic dermatoses. The pathophysiology of PG is yet incompletely understood but a prominent role of genetics facilitating immune dysregulation has been proposed. This study investigated the potential contribution of disrupted molecular pathways in determining the susceptibility and clinical severity of PG. Variant Enrichment Analysis, a bioinformatic pipeline applicable for Whole Exome Sequencing data was performed in unrelated PG patients. Eleven patients were enrolled, including 5 with unilesional and 6 with multilesional PG. Fourteen pathways were exclusively enriched in the "multilesional" group, mainly related to immune system (i.e., type I interferon signaling pathway), cell metabolism and structural functions. In the "unilesional" group, nine pathways were found to be exclusively enriched, mostly related to cell signaling and cell metabolism. Genetically altered pathways involved in immune system biology and wound repair appear to be nodal pathogenic drivers in PG pathogenesis.

摘要

坏疽性脓皮病(PG)是一种罕见的炎症性皮肤病,属于中性粒细胞皮肤病谱。PG 的病理生理学尚未完全了解,但已提出遗传易感性促进免疫失调的重要作用。本研究探讨了分子通路紊乱在决定 PG 易感性和临床严重程度方面的潜在作用。在无亲缘关系的 PG 患者中进行了变异富集分析,这是一种适用于全外显子组测序数据的生物信息学分析方法。共纳入 11 名患者,其中 5 名患有单发性 PG,6 名患有多发性 PG。在“多发性”组中,有 14 条通路是特异性富集的,主要与免疫系统(即 I 型干扰素信号通路)、细胞代谢和结构功能有关。在“单发性”组中,发现有 9 条通路是特异性富集的,主要与细胞信号转导和细胞代谢有关。涉及免疫系统生物学和伤口修复的遗传改变通路似乎是 PG 发病机制中的主要致病驱动因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10b/10039933/da71bf6f781c/41598_2023_31914_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10b/10039933/da71bf6f781c/41598_2023_31914_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10b/10039933/da71bf6f781c/41598_2023_31914_Fig1_HTML.jpg

相似文献

1
Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease.不同的分子通路在坏疽性脓皮病患者中被破坏,并与疾病的严重程度相关。
Sci Rep. 2023 Mar 25;13(1):4919. doi: 10.1038/s41598-023-31914-z.
2
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
3
What can inherited immunodeficiencies reveal about pyoderma gangrenosum?遗传性免疫缺陷病能揭示坏疽性脓皮病的哪些问题?
Exp Dermatol. 2024 Jan;33(1):e14954. doi: 10.1111/exd.14954. Epub 2023 Oct 17.
4
Pathophysiology of pyoderma gangrenosum (PG): an updated review.坏疽性脓皮病(PG)的病理生理学:最新综述。
J Am Acad Dermatol. 2015 Oct;73(4):691-8. doi: 10.1016/j.jaad.2015.06.021. Epub 2015 Aug 5.
5
Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.坏疽性脓皮病:疾病分子特征的系统综述。
Exp Dermatol. 2022 Apr;31(4):498-515. doi: 10.1111/exd.14534. Epub 2022 Feb 15.
6
What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.自身炎症性疾病对常见皮肤疾病(如坏疽性脓皮病)有何启示?评论。
Dermatol Clin. 2013 Jul;31(3):427-35. doi: 10.1016/j.det.2013.04.004. Epub 2013 May 10.
7
Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature.坏疽性脓皮病与系统性红斑狼疮:五例报告及文献复习
Lupus. 2015 Feb;24(2):130-7. doi: 10.1177/0961203314550227. Epub 2014 Sep 8.
8
Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.坏疽性脓皮病:21 例患者的研究及“临床治疗”分类的提出。
J Dermatolog Treat. 2011 Oct;22(5):254-60. doi: 10.3109/09546631003686069. Epub 2010 Jul 28.
9
Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.药物诱导性坏疽性脓皮病:一种理解坏疽性脓皮病发病机制的模型。
Br J Dermatol. 2017 Jul;177(1):72-83. doi: 10.1111/bjd.15193. Epub 2017 Jun 14.
10
Familial ulcerative pyoderma gangrenosum: a report of 2 kindred.家族性坏疽性脓皮病溃疡:2个家族的报告。
Cutis. 2002 Jun;69(6):427-30.

引用本文的文献

1
Disrupted Redox Regulation and Inflammatory Response in Pyoderma Gangrenosum.坏疽性脓皮病中氧化还原调节和炎症反应的破坏
Life (Basel). 2025 Apr 6;15(4):611. doi: 10.3390/life15040611.
2
Case Report: Spesolimab for pyoderma gangrenosum in an undifferentiated oligoarthritis patient receiving anti-IL-17 therapy.病例报告:司妥昔单抗用于一名接受抗IL-17治疗的未分化寡关节炎患者的坏疽性脓皮病
Front Immunol. 2025 Apr 7;16:1581996. doi: 10.3389/fimmu.2025.1581996. eCollection 2025.
3
Gasdermin D-dependent neutrophil extracellular traps exacerbate cytokine storm contributing to pyoderma gangrenosum pathogenesis.

本文引用的文献

1
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.坏疽性脓皮病:已确立和新兴药物治疗的最新文献综述。
Am J Clin Dermatol. 2022 Sep;23(5):615-634. doi: 10.1007/s40257-022-00699-8. Epub 2022 May 24.
2
Variant Enrichment Analysis to Explore Pathways Functionality in Complex Autoinflammatory Skin Disorders through Whole Exome Sequencing Analysis.通过全外显子组测序分析,对复杂自身炎症性皮肤病进行变异富集分析,以探索通路功能。
Int J Mol Sci. 2022 Feb 18;23(4):2278. doi: 10.3390/ijms23042278.
3
Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.
gasdermin D依赖性中性粒细胞胞外陷阱加剧细胞因子风暴,促进坏疽性脓皮病的发病机制。
iScience. 2025 Jan 30;28(3):111925. doi: 10.1016/j.isci.2025.111925. eCollection 2025 Mar 21.
4
The Pathophysiology and Treatment of Pyoderma Gangrenosum-Current Options and New Perspectives.坏疽性脓皮病的发病机制和治疗:现有选择和新视角。
Int J Mol Sci. 2024 Feb 19;25(4):2440. doi: 10.3390/ijms25042440.
5
New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.坏疽性脓皮病和化脓性汗腺炎的新治疗方法:综述。
J Dermatol. 2024 Feb;51(2):172-179. doi: 10.1111/1346-8138.17031. Epub 2023 Nov 27.
6
What can inherited immunodeficiencies reveal about pyoderma gangrenosum?遗传性免疫缺陷病能揭示坏疽性脓皮病的哪些问题?
Exp Dermatol. 2024 Jan;33(1):e14954. doi: 10.1111/exd.14954. Epub 2023 Oct 17.
7
Pyoderma Gangrenosum: Treatment Options.坏疽性脓皮病:治疗选择。
Drugs. 2023 Sep;83(14):1255-1267. doi: 10.1007/s40265-023-01931-3. Epub 2023 Aug 23.
8
Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.慢性复发性多灶性骨髓炎患者抗TNF治疗后发生坏疽性脓皮病:药物反应还是疾病的皮肤表现?结合典型病例报告对该主题的批判性综述
Front Med (Lausanne). 2023 May 31;10:1197273. doi: 10.3389/fmed.2023.1197273. eCollection 2023.
坏疽性脓皮病:疾病分子特征的系统综述。
Exp Dermatol. 2022 Apr;31(4):498-515. doi: 10.1111/exd.14534. Epub 2022 Feb 15.
4
Molecular and Cellular Characterization of Pyoderma Gangrenosum: Implications for the Use of Gene Expression.坏疽性脓皮病的分子和细胞特征:对基因表达应用的启示
J Invest Dermatol. 2022 Apr;142(4):1217-1220.e14. doi: 10.1016/j.jid.2021.08.431. Epub 2021 Sep 15.
5
Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation.自噬调节内皮细胞连接,以限制炎症期间中性粒细胞的渗出。
Immunity. 2021 Sep 14;54(9):1989-2004.e9. doi: 10.1016/j.immuni.2021.07.012. Epub 2021 Aug 6.
6
Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism.支链氨基酸:骨骼肌中的分解代谢及其对肌肉和全身代谢的影响
Front Physiol. 2021 Jul 20;12:702826. doi: 10.3389/fphys.2021.702826. eCollection 2021.
7
T/Interleukin-17A Contributes to the Effect of Maresin Conjugates in Tissue Regeneration 1 on Lipopolysaccharide-Induced Cardiac Injury.T/白细胞介素-17A 有助于马尿酸盐结合物在脂多糖诱导的心脏损伤中的组织再生 1 作用。
Front Immunol. 2021 Apr 26;12:674542. doi: 10.3389/fimmu.2021.674542. eCollection 2021.
8
bFGF and collagen matrix hydrogel attenuates burn wound inflammation through activation of ERK and TRK pathway.碱性成纤维细胞生长因子(bFGF)和胶原基质水凝胶通过激活 ERK 和 TRK 通路来减轻烧伤创面炎症。
Sci Rep. 2021 Feb 8;11(1):3357. doi: 10.1038/s41598-021-82888-9.
9
Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role.VEGFR-2介导的生理功能和病理作用的分子基础
Front Cell Dev Biol. 2020 Nov 16;8:599281. doi: 10.3389/fcell.2020.599281. eCollection 2020.
10
Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing.角质形成细胞自噬能够激活角质形成细胞和成纤维细胞,并促进伤口愈合。
Autophagy. 2021 Sep;17(9):2128-2143. doi: 10.1080/15548627.2020.1816342. Epub 2020 Sep 18.